Insights
Search Results
Client Highlights
10.16.26
Wilson Sonsini Advises Iambic Therapeutics on $150 Million Initial Public Offering
Wilson Sonsini advised Iambic Therapeutics, a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform, in connection with the company’s $150 million initial public offering (IPO). Iambic issued 9,375,000 shares of its common stock at a public offering price of $16 per share, with a 30-day option for the underwriters to purchase up to an additional 1,406,250 shares. Iambic’s common stock began trading on the Nasdaq Global Select Market on October 15, 2026, under the ticker symbol “IAM.”
Client Highlights
10.16.26
Wilson Sonsini Advises Recursion on $200 Million Follow-On Offering
On October 16, 2026, Recursion Pharmaceuticals, a clinical-stage company using AI-enabled drug discovery and development, closed an underwritten public offering of 61,540,000 shares of its Class A common stock at a public offering price of $3.25 per share. The gross proceeds from the offering were approximately $200 million, before deducting underwriting discounts and commissions and estimated offering expenses. Wilson Sonsini Goodrich & Rosati advised Recursion on the transaction.
Client Highlights
10.12.26
Wilson Sonsini Advises Armada Acquisition Corp. II on Business Combination with Evernorth Holdings
On October 9, 2026, Armada Acquisition Corp. II (Armada II), a special purpose acquisition company, and Evernorth Holdings (Evernorth), a digital asset treasury company building institutional access to the XRP economy, announced the completion of their business combination. Evernorth’s common stock is expected to begin trading on the Nasdaq Stock Market on October 12, 2026, under the ticker symbol “XRPN.” Investors included Arrington Capital, SBI Group, Ripple, Pantera Capital, Kraken, and GSR, among others.
News Articles
8.20.26
Five Wilson Sonsini Attorneys Named 2027 “Lawyer of the Year” Honorees by Best Lawyers
Five Wilson Sonsini attorneys have been named 2027 “Lawyer of the Year” honorees by The Best Lawyers in America®, one of the publication’s highest peer-reviewed distinctions. The honors span five practice areas and three markets and recognize Caz Hashemi, Martin W. Korman, Martin J. Waters, Patrick J. Schultheis, and Craig E. Sherman.
News Articles
6.04.26
Wilson Sonsini Practices, Attorneys Recognized in 2026 Chambers USA Guide
The 2026 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 44 geography-specific practice categories and named 87 Wilson Sonsini attorneys among the best in their fields. This year, the firm received four new practice area rankings, including in the nationwide National Security and Capital Markets: Convertible Debt categories, and three improved practice area rankings.
Client Highlights
4.14.26
Wilson Sonsini Advises Special Committee of the Board in Globalstar's Acquisition by Amazon
On April 14, 2026, Amazon and Globalstar announced they have entered into a definitive merger agreement under which Amazon will acquire Globalstar, a leading mobile satellite services (MSS) operator, a pioneer in non-geostationary orbit (NGSO) satellites and D2D technology, and a provider of critical and emergency communications to customers around the world. Wilson Sonsini Goodrich & Rosati is representing the special committee of Globalstar’s board of directors on the transaction.
Client Highlights
2.17.26
Wilson Sonsini Advises nLIGHT on $201 Million Follow-On Offering
On February 5, 2026, nLIGHT, Inc., a leading provider of high-power lasers for mission-critical directed energy, optical sensing, and advanced manufacturing applications, closed an underwritten public offering of 3,977,273 shares of its common stock at a public offering price of $44.00 per share. In addition, on February 9, 2026, nLIGHT closed the sale of an additional 596,590 shares of its common stock, at the same public offering price, pursuant to the full exercise of the underwriters’ option to purchase additional shares. The aggregate gross proceeds from the offering was approximately $201 million, before deducting the underwriting discounts and commissions and estimated offering expenses. Wilson Sonsini Goodrich & Rosati advised nLIGHT on the transaction.
Client Highlights
10.21.25
Wilson Sonsini Advises Armada Acquisition Corp. II on $1 Billion Business Combination with Evernorth Holdings
On October 20, 2025, Armada Acquisition Corp II (Armada II), a publicly traded special purpose acquisition company, and Evernorth Holdings Inc. (Evernorth), a newly formed Nevada corporation focused on enabling institutional-scale adoption of XRP, announced that they have entered into a definitive business combination agreement through which Evernorth will become a publicly listed company. The transaction is expected to raise more than $1 billion in gross proceeds, establishing Evernorth as the largest public XRP-treasury company and a first-of-its-kind institutional vehicle built to accelerate XRP adoption. Investors include SBI, Ripple, Rippleworks, and leading digital-asset and fintech investors such as Pantera Capital, Kraken, and GSR, with participation from Ripple co-founder Chris Larsen. Upon closing, the combined company will operate under the Evernorth name and is expected to trade on Nasdaq under the ticker symbol “XRPN,” subject to applicable listing requirements and other customary closing conditions.
News Articles
6.05.25
2025 Chambers USA Guide Recognizes Wilson Sonsini Practices, Attorneys
The 2025 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 39 geography-specific practice categories and named 86 Wilson Sonsini attorneys among the best in their fields. This year, the firm received three new practice area rankings, including in the Artificial Intelligence category, and four improved practice area rankings.
Client Highlights
4.30.25
Wilson Sonsini Advises Micron on $1.75 Billion Senior Notes Offering
On April 29, 2025, Micron Technology, Inc., completed its offering of (i) $500,000,000 aggregate principal amount of 5.65 percent senior notes due 2032 (the "2032 Notes") and (ii) $1,250,000,000 aggregate principal amount of 6.05 percent senior notes due 2035 (the "2035 Notes" and, together with the 2032 Notes, the "Notes"). Micron intends to use the net proceeds from the sale of the Notes to redeem its outstanding 4.185 percent Senior Notes due 2027 and for general corporate purposes. Wilson Sonsini Goodrich & Rosati advised Micron on the transaction.
Client Highlights
1.24.25
Wilson Sonsini Advises Micron on $1 Billion Senior Notes Offering
On January 16, 2025, Micron Technology, Inc., settled its offering of $1 billion aggregate principal amount of 5.80 percent senior notes due 2035. Micron intends to use the net proceeds from the sale of the notes to pay the redemption price of its outstanding 4.975 percent senior notes due 2026 and for general corporate purposes. Wilson Sonsini Goodrich & Rosati advised Micron on the transaction.
The Wilson Sonsini team representing Micron includes:
The Wilson Sonsini team representing Micron includes:
Client Highlights
8.09.24
Wilson Sonsini Advises Recursion on Definitive Agreement with Exscientia
On August 8, 2024, Recursion and Exscientia announced the companies have entered into a definitive agreement, combining Recursion, a leading clinical stage technology-enabled biotech company decoding biology to industrialize drug discovery, with Exscientia, a technology-driven clinical stage drug design and development company, committed to creating more effective medicines for patients, faster. Wilson Sonsini Goodrich & Rosati advised Recursion on the transaction.